NCT00345345 2022-05-03Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte LeukemiaNational Institutes of Health Clinical Center (CC)Phase 2 Completed29 enrolled 17 charts
NCT00387426 2014-05-28Sunitinib in Treating Patients With Idiopathic MyelofibrosisNational Cancer Institute (NCI)Phase 2 Terminated14 enrolled 5 charts